Camber Pharma Launches Generic Accolate® Tablets
Camber Pharmaceuticals announces the launch of Zafirlukast tablets, which is the generic version of Accolate.
Camber Pharmaceuticals is pleased to announce that it has launched Zafirlukast tablets, which is the generic version of Accolate®. Zafirlukast is used for chronic treatment of asthma, and to prevent asthma attacks in adults and children as young as 5 years old.
Zafirlukast tablets are available from Camber in 10 mg and 20 mg-60 ct bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
SOURCE: Camber Pharmaceuticals
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025